Evaluation of pembrolizumab monotherapy in patients with previously treated advanced salivary gland carcinoma in the phase 2 KEYNOTE-158 study
出版年份 2022 全文链接
标题
Evaluation of pembrolizumab monotherapy in patients with previously treated advanced salivary gland carcinoma in the phase 2 KEYNOTE-158 study
作者
关键词
-
出版物
EUROPEAN JOURNAL OF CANCER
Volume 171, Issue -, Pages 259-268
出版商
Elsevier BV
发表日期
2022-06-29
DOI
10.1016/j.ejca.2022.05.007
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Management of Salivary Gland Malignancy: ASCO Guideline
- (2021) Jessica L. Geiger et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase II trial cohort of nivolumab plus ipilimumab in patients (Pts) with recurrent/metastatic salivary gland cancers (R/M SGCs).
- (2021) Bharat Burman et al. JOURNAL OF CLINICAL ONCOLOGY
- Distant metastasis of salivary gland cancer: Incidence, management, and outcomes
- (2020) Ximena Mimica et al. CANCER
- Phase I, first-in-human trial of programmed cell death receptor-1 (PD-1) inhibitor, JTX-4014, in adult patients with advanced, refractory, solid tumors
- (2020) Kyriakos P. Papadopoulos et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study
- (2020) Aurélien Marabelle et al. LANCET ONCOLOGY
- NISCAHN: A phase II, multicenter nonrandomized trial aiming at evaluating nivolumab (N) in two cohorts of patients (pts) with recurrent/metastatic (R/M) salivary gland carcinoma of the head and neck (SGCHN), on behalf of the Unicancer Head & Neck Group.
- (2019) Jerome Fayette et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase II trial cohort of nivolumab plus ipilimumab in patients (Pts) with recurrent/metastatic adenoid cystic carcinoma (R/M ACC).
- (2019) Vatche Tchekmedyian et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical utility of pembrolizumab in the management of advanced solid tumors: an evidence-based review on the emerging new data
- (2019) Pauline du Rusquec et al. Cancer Management and Research
- Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study
- (2019) Aurelien Marabelle et al. JOURNAL OF CLINICAL ONCOLOGY
- Pembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma
- (2018) Roger B. Cohen et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Risk factors and prognosis for salivary gland adenoid cystic carcinoma in southern china
- (2017) Dai-qiao Ouyang et al. MEDICINE
- Risk Factors and Survival Associated with Distant Metastasis in Patients with Carcinoma of the Salivary Gland
- (2016) Soo Jung Nam et al. ANNALS OF SURGICAL ONCOLOGY
- High-grade histology as predictor of early distant metastases and decreased disease-free survival in salivary gland cancer irrespective of tumor subtype
- (2016) Marlen Haderlein et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
- (2016) Martin Reck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab versus Ipilimumab in Advanced Melanoma
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Review of Poly (ADP-ribose) Polymerase (PARP) Mechanisms of Action and Rationale for Targeting in Cancer and Other Diseases
- (2013) Julio Morales et al. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- Survival from salivary glands adenoid cystic carcinoma in European populations
- (2008) Laura Ciccolallo et al. ORAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started